BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang H, Mao W, Rodriguez-Aguayo C, Mangala LS, Bartholomeusz G, Iles LR, Jennings NB, Ahmed AA, Sood AK, Lopez-Berestein G, Lu Z, Bast RC Jr. Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability. Clin Cancer Res 2018;24:5072-84. [PMID: 30084832 DOI: 10.1158/1078-0432.CCR-18-0504] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Hao X, Zhang Y, Lu Y, Han G, Rong D, Sun G, Sun G, Tang W, Wu J, Wang X. STK39 enhances the progression of Cholangiocarcinoma via PI3K/AKT pathway. iScience 2021;24:103223. [PMID: 34746696 DOI: 10.1016/j.isci.2021.103223] [Reference Citation Analysis]
2 Yu HL, Ma XD, Tong JF, Li JQ, Guan XJ, Yang JH. WTAP is a prognostic marker of high-grade serous ovarian cancer and regulates the progression of ovarian cancer cells. Onco Targets Ther 2019;12:6191-201. [PMID: 31496724 DOI: 10.2147/OTT.S205730] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 8.3] [Reference Citation Analysis]
3 Zhang C, Wang X, Fang D, Xu P, Mo X, Hu C, Abdelatty A, Wang M, Xu H, Sun Q, Zhou G, She J, Xia J, Hui KM, Xia H. STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway. Theranostics 2021;11:2108-22. [PMID: 33500714 DOI: 10.7150/thno.48112] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Gjyrezi A, Xie F, Voznesensky O, Khanna P, Calagua C, Bai Y, Kung J, Wu J, Corey E, Montgomery B, Mace S, Gianolio DA, Bubley GJ, Balk SP, Giannakakou P, Bhatt RS. Taxane resistance in prostate cancer is mediated by decreased drug-target engagement. J Clin Invest 2020;130:3287-98. [PMID: 32478682 DOI: 10.1172/JCI132184] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
5 Wu Y, Du H, Zhan M, Wang H, Chen P, Du D, Liu X, Huang X, Ma P, Peng D, Sun L, Yuan S, Ding J, Lu L, Jiang J. Sepiapterin reductase promotes hepatocellular carcinoma progression via FoxO3a/Bim signaling in a nonenzymatic manner. Cell Death Dis 2020;11:248. [PMID: 32312975 DOI: 10.1038/s41419-020-2471-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
6 Huang H, Yan L, Zhong J, Hong L, Zhang N, Luo X. Circ_0025033 deficiency suppresses paclitaxel resistance and malignant development of paclitaxel-resistant ovarian cancer cells by modulating the miR-532-3p/FOXM1 network. Immunopharmacol Immunotoxicol 2022;:1-12. [PMID: 35196944 DOI: 10.1080/08923973.2022.2038194] [Reference Citation Analysis]
7 Noonan AM, Cousins A, Anderson D, Zeligs KP, Bunch K, Hernandez L, Shibuya Y, Goldlust IS, Guha R, Ferrer M, Thomas CJ, Annunziata CM. Matrix Drug Screen Identifies Synergistic Drug Combinations to Augment SMAC Mimetic Activity in Ovarian Cancer. Cancers (Basel) 2020;12:E3784. [PMID: 33334024 DOI: 10.3390/cancers12123784] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Nakatake M, Kurosaki H, Kuwano N, Horita K, Ito M, Kono H, Okamura T, Hasegawa K, Yasutomi Y, Nakamura T. Partial Deletion of Glycoprotein B5R Enhances Vaccinia Virus Neutralization Escape while Preserving Oncolytic Function. Mol Ther Oncolytics 2019;14:159-71. [PMID: 31236440 DOI: 10.1016/j.omto.2019.05.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
9 Zheng H, Zhang M, Ma S, Yang W, Xie S, Wang Y, Liu Y, Kai J, Ma Q, Lu R, Guo L. Identification of the key genes associated with chemotherapy sensitivity in ovarian cancer patients. Cancer Med 2020;9:5200-9. [PMID: 32441484 DOI: 10.1002/cam4.3122] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Alharbi M, Lai A, Sharma S, Kalita-de Croft P, Godbole N, Campos A, Guanzon D, Salas-Burgos A, Carrion F, Zuñiga FA, Perrin L, He Y, Pejovic T, Winters C, Morgan T, Hooper JD, Rice GE, Salomon C. Extracellular Vesicle Transmission of Chemoresistance to Ovarian Cancer Cells Is Associated with Hypoxia-Induced Expression of Glycolytic Pathway Proteins, and Prediction of Epithelial Ovarian Cancer Disease Recurrence. Cancers (Basel) 2021;13:3388. [PMID: 34298602 DOI: 10.3390/cancers13143388] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Wang X, Frederick J, Wang H, Hui S, Backman V, Ji Z. Spike-in normalization for single-cell RNA-seq reveals dynamic global transcriptional activity mediating anticancer drug response. NAR Genom Bioinform 2021;3:lqab054. [PMID: 34159316 DOI: 10.1093/nargab/lqab054] [Reference Citation Analysis]
12 Wang X, Li C, Chen T, Li W, Zhang H, Zhang D, Liu Y, Han D, Li Y, Li Z, Luo D, Zhang N, Yang Q. Identification and Validation of a Five-Gene Signature Associated With Overall Survival in Breast Cancer Patients. Front Oncol 2021;11:660242. [PMID: 34513664 DOI: 10.3389/fonc.2021.660242] [Reference Citation Analysis]